The journal retracts the article titled, “Systematic Review and Meta-Analysis of Clinical Efficacy and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections” [1], cited above.
Following its publication, concerns were raised about the meta-analysis which included both the TANGO II randomized trial and a post hoc analysis of a subset of the same trial population, resulting in overlapping datasets and double-counting of patients in this publication [1].
In accordance with the journal’s standard procedures, an investigation was conducted by the Editorial Office and the Editorial Board, that confirmed the presence of overlapping datasets and consequent double-counting of data, resulting in errors in the meta-analysis findings. While the authors collaborated with the investigation and acknowledged the error, the Editorial Board determined that the issues identified exceeded what could be addressed through a standard correction.
As a result, the Editorial Board decided to retract this article in line with MDPI policy on retraction.
This retraction was approved by the Editor-in-Chief of the journal International Journal of Molecular Sciences.
The authors have been informed of this retraction and have indicated their agreement with this decision. The authors state that there was an error in the selection and data synthesis.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Bucataru A., Turcu-Stiolica A., Calina D., Balasoiu A.T., Zlatian O.M., Osman A., Balasoiu M., Ghenea A.E. RETRACTED: Systematic Review and Meta-Analysis of Clinical Efficacy and Safety of Meropenem-Vaborbactam Versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections. Int. J. Mol. Sci. 2024;25:9574. doi: 10.3390/ijms25179574. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
